Sympatholytic treatment of "paralytic" ileus.
D000928:Antidepressive Agents / Q000627:therapeutic use*; D002090:Butyrophenones / Q000627:therapeutic use*; D002219:Carbamates / Q000627:therapeutic use; D002395:Catecholamines / Q000037:antagonists & inhibitors; D002746:Chlorpromazine / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D004357:Drug Synergism; D005461:Fluorine / Q000627:therapeutic use*; D005767:Gastrointestinal Diseases / Q000503:physiopathology; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006801:Humans; D007082:Ileum / Q000187:drug effects / Q000503:physiopathology*; D007410:Intestinal Diseases / Q000188:drug therapy*; D009388:Neostigmine / Q000627:therapeutic use*; D010243:Paralysis / Q000175:diagnosis / Q000188:drug therapy*; D010880:Piperidines / Q000627:therapeutic use*; D011726:Pyridinium Compounds / Q000627:therapeutic use; D014272:Trifluperidol / Q000627:therapeutic use
D000928:Antidepressive Agents; D002090:Butyrophenones; D002219:Carbamates; D002395:Catecholamines; D010880:Piperidines; D011726:Pyridinium Compounds; D005461:Fluorine; D009388:Neostigmine; D014272:Trifluperidol; D002746:Chlorpromazine